It showed that CD3+T cells, CD4+T cells, CD8+T cells, CD4+/CD8+ ratio, DNT cells, NK cells, and LMR were significantly lower in the breast cancer group than in the group with benign breast lesions. This evidence concerns the gene CD8A and breast cancer.